Basic Information
RNALocate ID: RLID:01001654
RNA Symbol: hsa-miR-212-3p
Localization: Cytoplasm
RNA Information
RNA Name: hsa-miR-212
RNA ID: miRBase:MIMAT0000269
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24918059
Tissue/Cell Line: Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa)
Method: Microarray
Description: Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001655 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001656 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11001494 Exosome Plasma 19289371
RLID:11001495 Exosome Saliva 19627513
RLID:11001496 Exosome Brain tissue 23382797
RLID:11001497 Exosome Plasma 23663360
RLID:11001498 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001499 Microvesicle Follicular fluid 23666971
RLID:11001500 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000330 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
RLID-D:11001170 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-212-3p Oral squamous cell carcinoma MNDR-E-MI-28795
MNDR hsa-miR-212-3p Medulloblastoma MNDR-E-MI-28796
MNDR hsa-miR-212-3p High-grade serous ovarian carcinoma MNDR-E-MI-28797
MNDR hsa-miR-212-3p Ovarian clear cell carcinoma MNDR-E-MI-28798
MNDR hsa-miR-212-3p Uterine corpus endometrial carcinoma MNDR-E-MI-28799
MNDR hsa-miR-212-3p Lymphoma MNDR-E-MI-28800
MNDR hsa-miR-212-3p Non-hodgkin lymphoma MNDR-E-MI-28801
MNDR hsa-miR-212-3p Estrogen-receptor positive breast cancer MNDR-E-MI-28802
MNDR hsa-miR-212-3p Progesterone-receptor positive breast cancer MNDR-E-MI-28803
MNDR hsa-miR-212-3p Her2-receptor positive breast cancer MNDR-E-MI-28804
MNDR hsa-miR-212-3p Anencephaly MNDR-E-MI-28805
MNDR hsa-miR-212-3p Familial temporal lobe epilepsy 3 MNDR-E-MI-28806
MNDR hsa-miR-212-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-28807
MNDR hsa-miR-212-3p Chronic lymphocytic leukemia MNDR-E-MI-28808
MNDR hsa-miR-212-3p Gastric cancer MNDR-E-MI-28809
MNDR hsa-miR-212-3p Alzheimer disease MNDR-E-MI-28810
MNDR hsa-miR-212-3p Dysautonomia familial MNDR-E-MI-28811
MNDR hsa-miR-212-3p Lewy body dementia MNDR-E-MI-28812
MNDR hsa-miR-212-3p Primary biliary cirrhosis MNDR-E-MI-28813
MNDR hsa-miR-212-3p Friedreich ataxia MNDR-E-MI-28814
MNDR hsa-miR-212-3p Huntington disease MNDR-E-MI-28815
MNDR hsa-miR-212-3p Chorea MNDR-E-MI-28816
MNDR hsa-miR-212-3p Cardiovascular disease MNDR-E-MI-28817
MNDR hsa-miR-212-3p Uterine fibroid MNDR-E-MI-28818
MNDR hsa-miR-212-3p Lung cancer MNDR-E-MI-28819
MNDR hsa-miR-212-3p Fragile x syndrome MNDR-E-MI-28820
MNDR hsa-miR-212-3p Parkinson disease MNDR-E-MI-28821
MNDR hsa-miR-212-3p Breast cancer MNDR-E-MI-28822
MNDR hsa-miR-212-3p Pituitary neoplasms MNDR-E-MI-28823
MNDR hsa-miR-212-3p Pancreatic cancer MNDR-E-MI-28824
MNDR hsa-miR-212-3p Melanoma MNDR-E-MI-28825
MNDR hsa-miR-212-3p Nephroblastoma MNDR-E-MI-28826
MNDR hsa-miR-212-3p Colon cancer MNDR-E-MI-28827
MNDR hsa-miR-212-3p Ischemic attack transient MNDR-E-MI-28828
MNDR hsa-miR-212-3p Colon adenocarcinoma MNDR-E-MI-28829
MNDR hsa-miR-212-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-28830
MNDR hsa-miR-212-3p Prostate adenocarcinoma MNDR-E-MI-28831
MNDR hsa-miR-212-3p Glioblastoma MNDR-E-MI-28832
MNDR hsa-miR-212-3p Glioma MNDR-E-MI-28833
MNDR hsa-miR-212-3p Amyotrophic lateral sclerosis MNDR-E-MI-28834
MNDR hsa-miR-212-3p Temporal lobe epilepsy MNDR-E-MI-28835
MNDR hsa-miR-212-3p Osteosarcoma MNDR-E-MI-28836
MNDR hsa-miR-212-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-28837
MNDR hsa-miR-212-3p Uterine cancer MNDR-E-MI-28838
MNDR hsa-miR-212-3p Pituitary adenoma MNDR-E-MI-28839
MNDR hsa-miR-212-3p Lung squamous cell carcinoma MNDR-E-MI-28840
MNDR hsa-miR-212-3p Non-small cell lung cancer MNDR-E-MI-28841
MNDR hsa-miR-212-3p Lung adenocarcinoma MNDR-E-MI-28842
MNDR hsa-miR-212-3p Thyroid carcinoma MNDR-E-MI-28843
MNDR hsa-miR-212-3p Ovarian carcinoma MNDR-E-MI-28844
MNDR hsa-miR-212-3p Bladder urothelial carcinoma MNDR-E-MI-28845
MNDR hsa-miR-212-3p Pancreatic adenocarcinoma MNDR-E-MI-28846
MNDR hsa-miR-212-3p Carcinoma renal cell MNDR-E-MI-28847
MNDR hsa-miR-212-3p Kidney renal papillary cell carcinoma MNDR-E-MI-28848
MNDR hsa-miR-212-3p Clear cell renal cell carcinoma MNDR-E-MI-28849
MNDR hsa-miR-212-3p Cholangiocarcinoma MNDR-E-MI-28850
MNDR hsa-miR-212-3p Growth hormone-secreting pituitary adenoma MNDR-E-MI-28851
MNDR hsa-miR-212-3p Hepatocellular carcinoma MNDR-E-MI-28852
MNDR hsa-miR-212-3p B-cell lymphoma MNDR-E-MI-28853
MNDR hsa-miR-212-3p Malignant pleural mesothelioma MNDR-E-MI-28854
MNDR hsa-miR-212-3p Chronic myeloid leukemia MNDR-E-MI-28855
MNDR hsa-miR-212-3p Burkitt lymphoma MNDR-E-MI-28856
MNDR hsa-miR-212-3p Tonsil cancer MNDR-E-MI-28857
MNDR hsa-miR-212-3p Skin cutaneous melanoma MNDR-E-MI-28858
MNDR hsa-miR-212-3p Skin melanoma MNDR-E-MI-28859
MNDR hsa-miR-212-3p Frontotemporal dementia MNDR-E-MI-28860
MNDR hsa-miR-212-3p Colorectal cancer MNDR-E-MI-28861
MNDR hsa-miR-212-3p Nasopharynx carcinoma MNDR-E-MI-28862
MNDR hsa-miR-212-3p Acute lymphocytic leukemia MNDR-E-MI-28863
MNDR hsa-miR-212-3p Nasopharyngeal cancer MNDR-E-MI-28864
MNDR hsa-miR-212-3p Gait ataxia MNDR-E-MI-28865
MNDR hsa-miR-212-3p Breast cancer her3+ negative MNDR-E-MI-28866
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCG2 Homo sapiens RR00024742
TOP